Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
RRBI Quote, Financials, Valuation and Earnings
Last price:
$54.82
Seasonality move
:
-6.19%
Day range:
$53.13 - $55.48
52-week range:
$42.78 - $62.13
Dividend yield:
0.65%
P/E ratio:
11.68x
P/S ratio:
3.64x
P/B ratio:
1.16x
Volume:
27.4K
Avg. volume:
12.9K
1-year change:
-0.23%
Market cap:
$376M
Revenue:
$106.6M
EPS (TTM):
$4.75
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $78.5M | $91.1M | $95.2M | $104.7M | $106.6M | |
| Revenue Growth (YoY) | 7.61% | 16.13% | 4.48% | 10.01% | 1.76% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.8M | $32.1M | $33.4M | $35.7M | $38.5M | |
| Other Inc / (Exp) | $133K | $1.5M | $19K | -$527K | -$14K | |
| Operating Expenses | $28.8M | $32.1M | $33.4M | $35.7M | $38.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $30.5M | $34.5M | $40.1M | $45M | $42.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.6M | $6.3M | $7.1M | $8.1M | $8.1M | |
| Net Income to Company | $24.8M | $28.1M | $33M | $36.9M | $34.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $24.8M | $28.1M | $33M | $36.9M | $34.9M | |
| Basic EPS (Cont. Ops) | $3.51 | $3.84 | $4.53 | $5.14 | $4.87 | |
| Diluted EPS (Cont. Ops) | $3.49 | $3.83 | $4.51 | $5.13 | $4.86 | |
| Weighted Average Basic Share | $7.1M | $7.3M | $7.3M | $7.2M | $7.2M | |
| Weighted Average Diluted Share | $7.1M | $7.3M | $7.3M | $7.2M | $7.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $40.6M | $42.8M | $45.7M | $52.7M | $75.1M | |
| Revenue (Reported) | $78.5M | $91.1M | $95.2M | $104.7M | $106.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $40.6M | $42.8M | $45.7M | $52.7M | $75.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $23.4M | $23.4M | $27.8M | $26.1M | $27.6M | |
| Revenue Growth (YoY) | 15.43% | 0% | 18.63% | -6.2% | 5.81% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.3M | $8.2M | $9.2M | $9.8M | $10M | |
| Other Inc / (Exp) | $125K | -$41K | $16K | -$113K | $107K | |
| Operating Expenses | $8.3M | $8.2M | $9.2M | $9.8M | $10M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.9M | $9.9M | $12.3M | $9.9M | $10.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.6M | $1.8M | $2.1M | $1.9M | $2.1M | |
| Net Income to Company | $7.3M | $8.1M | $10.2M | $8M | $8.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $7.3M | $8.1M | $10.2M | $8M | $8.8M | |
| Basic EPS (Cont. Ops) | $0.99 | $1.12 | $1.42 | $1.12 | $1.28 | |
| Diluted EPS (Cont. Ops) | $0.99 | $1.12 | $1.42 | $1.12 | $1.27 | |
| Weighted Average Basic Share | $7.3M | $7.3M | $7.2M | $7.2M | $6.9M | |
| Weighted Average Diluted Share | $7.3M | $7.3M | $7.2M | $7.2M | $6.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $10.8M | $11.3M | $14.1M | $19.5M | $23.3M | |
| Revenue (Reported) | $23.4M | $23.4M | $27.8M | $26.1M | $27.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $10.8M | $11.3M | $14.1M | $19.5M | $23.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $86.8M | $95.6M | $100.8M | $108.5M | $106.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $31.1M | $33.1M | $35.3M | $37.9M | $39.5M | |
| Other Inc / (Exp) | $1.4M | $175K | -$580K | -$167K | $194K | |
| Operating Expenses | $31.1M | $33.1M | $35.3M | $37.9M | $39.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $33.9M | $38.6M | $42.8M | $45.2M | $41M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.3M | $6.9M | $7.6M | $8.4M | $7.8M | |
| Net Income to Company | $27.6M | $31.7M | $35.2M | $36.8M | $33.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $27.6M | $31.7M | $35.2M | $36.8M | $33.2M | |
| Basic EPS (Cont. Ops) | $3.77 | $4.34 | $4.90 | $5.13 | $4.76 | |
| Diluted EPS (Cont. Ops) | $3.76 | $4.34 | $4.89 | $5.12 | $4.75 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $42.8M | $44.8M | $48.5M | $69.9M | $87.8M | |
| Revenue (Reported) | $86.8M | $95.6M | $100.8M | $108.5M | $106.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $42.8M | $44.8M | $48.5M | $69.9M | $87.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $66.5M | $71M | $76.6M | $80.3M | $80.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.8M | $24.8M | $26.7M | $29M | $29.9M | |
| Other Inc / (Exp) | $1.4M | $93K | -$506K | -$146K | $63K | |
| Operating Expenses | $23.8M | $24.8M | $26.7M | $29M | $29.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $25.6M | $29.8M | $32.5M | $32.7M | $30.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.7M | $5.3M | $5.8M | $6.2M | $5.9M | |
| Net Income to Company | $20.9M | $24.4M | $26.7M | $26.6M | $24.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $20.9M | $24.4M | $26.7M | $26.6M | $24.9M | |
| Basic EPS (Cont. Ops) | $2.85 | $3.35 | $3.72 | $3.71 | $3.60 | |
| Diluted EPS (Cont. Ops) | $2.84 | $3.35 | $3.72 | $3.70 | $3.59 | |
| Weighted Average Basic Share | $22M | $21.9M | $21.5M | $21.5M | $20.8M | |
| Weighted Average Diluted Share | $22M | $22M | $21.6M | $21.6M | $20.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $32.1M | $34.1M | $36.9M | $54.1M | $66.8M | |
| Revenue (Reported) | $66.5M | $71M | $76.6M | $80.3M | $80.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $32.1M | $34.1M | $36.9M | $54.1M | $66.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $133.3M | $447.2M | $784.9M | $278.4M | $305.4M | |
| Short Term Investments | $335.6M | $498.2M | $659.2M | $614.4M | $570.1M | |
| Accounts Receivable, Net | $5.3M | $6.9M | $6.2M | $8.8M | $9.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $474.1M | $952.3M | $1.5B | $901.6M | $885.5M | |
| Property Plant And Equipment | $46.3M | $51.1M | $51.8M | $58.5M | $60.7M | |
| Long-Term Investments | $340.9M | $505.7M | $670.5M | $779.5M | $716.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2B | $2.6B | $3.2B | $3.1B | $3.1B | |
| Accounts Payable | $2.2M | $1.8M | $1.3M | $1.6M | $8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.2M | $1.8M | $1.3M | $1.6M | $8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7B | $2.4B | $2.9B | $2.8B | $2.8B | |
| Common Stock | $68.1M | $68.1M | $60.2M | $60.1M | $55.1M | |
| Other Common Equity Adj | -$24K | $6.9M | -$3.8M | -$71.2M | -$60.5M | |
| Common Equity | $251.9M | $285.5M | $298.2M | $265.8M | $303.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $251.9M | $285.5M | $298.2M | $265.8M | $303.9M | |
| Total Liabilities and Equity | $2B | $2.6B | $3.2B | $3.1B | $3.1B | |
| Cash and Short Terms | $468.9M | $945.4M | $1.4B | $892.8M | $875.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $270.9M | $730.6M | $301.1M | $322.2M | $232.6M | |
| Short Term Investments | $467.7M | $568.2M | $609.7M | $529M | $560.6M | |
| Accounts Receivable, Net | $6.6M | $5.9M | $7.8M | $8.8M | $9.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $745.2M | $1.3B | $918.6M | $860M | $802.7M | |
| Property Plant And Equipment | $48.8M | $51.3M | $57.1M | $60.2M | $60.5M | |
| Long-Term Investments | $475.2M | $579.6M | $767.9M | $677.5M | $700M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.5B | $3B | $3.1B | $3.1B | $3.1B | |
| Accounts Payable | $1.8M | $1.3M | $1.2M | $6.8M | $11.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.8M | $1.3M | $1.2M | $6.8M | $11.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.2B | $2.7B | $2.8B | $2.8B | $2.8B | |
| Common Stock | $68.1M | $65.1M | $60.1M | $58M | $41.4M | |
| Other Common Equity Adj | $6.4M | -$61K | -$83.7M | -$77.5M | -$49.6M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $278.1M | $298.7M | $243.4M | $282M | $324.3M | |
| Total Liabilities and Equity | $2.5B | $3B | $3.1B | $3.1B | $3.1B | |
| Cash and Short Terms | $738.6M | $1.3B | $910.8M | $851.2M | $793.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $24.8M | $28.1M | $33M | $36.9M | $34.9M | |
| Depreciation & Amoritzation | $2.4M | $2.4M | $2.6M | $2.6M | $2.7M | |
| Stock-Based Compensation | $314K | $338K | $319K | $359K | $361K | |
| Change in Accounts Receivable | -$238K | -$1.6M | $635K | -$2.6M | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $26.4M | $12.8M | $62.3M | $45.9M | $40.1M | |
| Capital Expenditures | $3.8M | $7M | $3.4M | $8.4M | $4.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$134.8M | -$316.3M | -$284.7M | -$438.7M | -$8.7M | |
| Dividends Paid (Ex Special Dividend) | -$1.3M | -$1.8M | -$2M | -$2M | -$2.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $50M | -- | -- | $60M | |
| Long-Term Debt Repaid | -$11.3M | -$50M | -- | -- | -$60M | |
| Repurchase of Common Stock | -- | -$122K | -$7.9M | -$218K | -$5M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $89.8M | $617.4M | $560.1M | -$113.6M | -$4.3M | |
| Beginning Cash (CF) | $151.9M | $133.3M | $447.2M | $784.9M | $278.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$18.6M | $313.9M | $337.7M | -$506.5M | $27M | |
| Ending Cash (CF) | $133.3M | $447.2M | $784.9M | $278.4M | $305.4M | |
| Levered Free Cash Flow | $22.7M | $5.8M | $58.8M | $37.4M | $35.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.3M | $8.1M | $10.2M | $8M | $8.8M | |
| Depreciation & Amoritzation | $606K | $635K | $638K | $683K | $848K | |
| Stock-Based Compensation | $70K | $67K | $94K | $87K | $101K | |
| Change in Accounts Receivable | -$125K | $112K | -$426K | -$539K | $105K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.8M | $14.7M | $17.1M | $14.1M | $17.4M | |
| Capital Expenditures | $3.5M | $495K | $1.2M | $1.5M | $395K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$92.7M | -$85.3M | -$18.3M | $52M | -$24.7M | |
| Dividends Paid (Ex Special Dividend) | -$440K | -$510K | -$503K | -$572K | -$615K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$60M | -- | |
| Repurchase of Common Stock | -$122K | -$804K | -- | -$1.2M | -$3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $124.1M | $133.7M | -$54.2M | $34M | $26.9M | |
| Beginning Cash (CF) | $241.4M | $667.5M | $356.4M | $222.1M | $213.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $29.5M | $63.1M | -$55.3M | $100.1M | $19.6M | |
| Ending Cash (CF) | $270.9M | $730.6M | $301.1M | $322.2M | $232.6M | |
| Levered Free Cash Flow | -$5.3M | $14.2M | $16M | $12.6M | $17M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $27.6M | $31.7M | $35.2M | $36.8M | $33.2M | |
| Depreciation & Amoritzation | $2.4M | $2.5M | $2.6M | $2.7M | $3M | |
| Stock-Based Compensation | $350K | $313K | $338K | $369K | $418K | |
| Change in Accounts Receivable | -$1.7M | $690K | -$1.9M | -$996K | -$687K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $14.1M | $54.2M | $47.5M | $42.5M | $42.3M | |
| Capital Expenditures | $6.5M | $4.8M | $7.8M | $5.8M | $3.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$365.2M | -$100.2M | -$561.8M | $19.5M | -$100M | |
| Dividends Paid (Ex Special Dividend) | -$1.3M | -$2M | -$2M | -$2.2M | -$2.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$122K | -$3M | -$5.1M | -$2.1M | -$16.7M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $515.7M | $505.7M | $84.8M | -$40.9M | -$31.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $164.6M | $459.7M | -$429.5M | $21.1M | -$89.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.6M | $49.4M | $39.7M | $36.7M | $38.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.9M | $24.4M | $26.7M | $26.6M | $24.9M | |
| Depreciation & Amoritzation | $1.8M | $1.9M | $1.9M | $2M | $2.3M | |
| Stock-Based Compensation | $265K | $240K | $259K | $269K | $326K | |
| Change in Accounts Receivable | -$1.4M | $953K | -$1.5M | $52K | $480K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.6M | $50.1M | $35.3M | $32M | $34.2M | |
| Capital Expenditures | $4.1M | $1.9M | $6.3M | $3.7M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$342.4M | -$126.4M | -$403.6M | $54.7M | -$36.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.3M | -$1.5M | -$1.5M | -$1.7M | -$1.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $50M | -- | -- | $60M | -- | |
| Long-Term Debt Repaid | -$50M | -- | -- | -$60M | -- | |
| Repurchase of Common Stock | -$122K | -$3M | -$218K | -$2.1M | -$13.8M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $471.4M | $359.7M | -$115.6M | -$42.9M | -$70.4M | |
| Beginning Cash (CF) | $455.1M | $1.7B | $1.7B | $729.7M | $748.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $137.6M | $283.4M | -$483.8M | $43.8M | -$72.8M | |
| Ending Cash (CF) | $592.7M | $2B | $1.2B | $773.5M | $675.5M | |
| Levered Free Cash Flow | $4.5M | $48.2M | $29M | $28.3M | $31.8M | |
Get RRBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RRBI
Sector
P/E ratio
11.68x
11.99x
PEG ratio
--
0.36x
P/B ratio
1.16x
1.05x
Price / LTM sales
3.64x
2.55x
Growth Metrics
RRBI
Sector
Revenue growth
5.81%
6.08%
Earnings growth
13.39%
6.45%
Revenue (5-year growth)
7.89%
5.85%
Earnings forecast
$1.19
$0.56
Profitability
RRBI
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
10.95%
5.27%
Return on assets
1.08%
0.98%
Return on equity
10.95%
9.43%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
30
Estimated Next Earnings Date
Jan
29
Balance Sheet
RRBI
Sector
Total cash
$793.2M
$615.3M
Short term investments
$570.1M
$408.4M
Total assets
$3.1B
$4.5B
Long term debt
--
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
